Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cross-reactivity00:42

Cross-reactivity

31.0K
Overview
31.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Prospective Audit and Feedback of Targeted Antimicrobials Use at a Tertiary Care Hospital in the United Arab Emirates.

Antibiotics (Basel, Switzerland)·2025
Same author

Sulopenem Etzadroxil/Probenecid.

Hospital pharmacy·2025
Same author

Axatilimab.

Hospital pharmacy·2025
Same author

Respiratory Syncytial Virus Vaccine (mRNA).

Hospital pharmacy·2024
Same author

Resmetirom.

Hospital pharmacy·2024
Same author

Cefepime/Enmetazobactam.

Hospital pharmacy·2024
Same journal

Stability of Diluted Intravenous Metronidazole in 0.9% Sodium Chloride.

Hospital pharmacy·2026
Same journal

Response to Comment on "Early Versus Later Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".

Hospital pharmacy·2026
Same journal

Significant Published Articles in 2025 for Pharmacy Nutrition Support Practice.

Hospital pharmacy·2026
Same journal

Comment on "Early Versus Later Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".

Hospital pharmacy·2026
Same journal

Comparison of Cystatin C-Based and Serum Creatinine-Based Renal Function Estimates Against Timed Urine Collection in Critically Ill Patients.

Hospital pharmacy·2026
Same journal

Comment on "Pharmacy Physiotherapy Interprofessional Education and Practice".

Hospital pharmacy·2026
查看所有相关文章

相关实验视频

Updated: Jun 26, 2025

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
09:39

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Published on: September 17, 2019

6.9K

这就是Idarucizumab.

Dennis J Cada1, Anne P Kim1, Danial E Baker2

  • 1Drug Information Resident, College of Pharmacy, Washington State University Spokane.

Hospital pharmacy
|May 15, 2024
PubMed
概括
此摘要是机器生成的。

单式专著服务为药学和治疗委员会提供每月的药物专著,包括药物利用评估和药物类别审查. 该服务有助于医疗保健设施的知情药物管理和表单决策.

更多相关视频

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

3.5K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

7.8K

相关实验视频

Last Updated: Jun 26, 2025

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
09:39

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Published on: September 17, 2019

6.9K
Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

3.5K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

7.8K

科学领域:

  • 制药科学 制药科学
  • 临床药房 临床药房
  • 药物信息 药物信息

背景情况:

  • 药品和治疗委员会需要最新的药物信息来管理表单.
  • 新发布的药物和处于试验后期阶段的药物需要全面评估.
  • 有效药物使用评估 (MUE) 对患者安全和医疗保健经济至关重要.

研究的目的:

  • 为了提供一个详细的概述的表格式专著服务.
  • 突出该服务对医疗保健专业人员,特别是药品和治疗委员会的实用性.
  • 告知潜在订阅者关于服务的内容和好处.

主要方法:

  • 该服务每月提供5-6篇关于新药或晚期试验药物的详细专著.
  • 包括药房和护理服务的1页摘要专著.
  • 每月提供全面的药物利用评估/药物使用评估 (DUE/MUE).
  • 具有每月的药物类别审查,在"医院药房"杂志上发表的精选评论.

主要成果:

  • 订阅者可以通过印刷和在线访问专著.
  • 专著可以根据具体的设施需求进行定制.
  • 2016年3月的主题包括necitumumab,talimogene laherparepvec,asfotase alfa,trabectedin和 osimertinib. 这些药物在2016年3月发表的论文中被列为主题.
  • 此外,还提供了一份专注于受体聚合物的安全MUE.

结论:

  • 表单单独写服务是基于证据的药物信息的宝贵资源.
  • 它支持药物选择,使用和管理的知情决策.
  • 该服务通过及时和相关的药物数据来增强药房实践和患者护理.